Perez, Ruth G.

A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis

Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 598

α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells

Peng, X. M., Tehranian, R., Dietrich, P., Stefanis, L., & Perez, R. G. (2005) · Journal of Cell Science

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 249

Could a loss of α‐synuclein function put dopaminergic neurons at risk?

Perez, R. G., & Hastings, T. G. (2004) · Journal of Neurochemistry

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 133

Serine 129 Phosphorylation Reduces the Ability of α-Synuclein to Regulate Tyrosine Hydroxylase and Protein Phosphatase 2A in Vitro and in Vivo

Lou, H., Montoya, S. E., Alerte, T. N. M., Wang, J., Wu, J., Peng, X., Hong, C.-S., Friedrich, E. E., Mader, S. A., Pedersen, C. J., et al. (2010) · Journal of Biological Chemistry

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 115

α-Synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: Lessons from viral transduction of knockout mice

Alerte, T. N. M., Akinfolarin, A. A., Friedrich, E. E., Mader, S. A., Hong, C.-S., & Perez, R. G. (2008) · Neuroscience Letters

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 98

Rapid activation of ERK by 6‐hydroxydopamine promotes survival of dopaminergic cells

Lin, E., Cavanaugh, J. E., Leak, R. K., Perez, R. G., & Zigmond, M. J. (2008) · Journal of Neuroscience Research

Parkinson's Disease Mechanisms and TreatmentsMelanoma and MAPK Pathways

Cited by 62